Semaglutide evaluation
Your provider reviews your health history, medications, previous treatment, and weight-related goals.
Provider-guided semaglutide treatment with personalized dosing, ongoing follow-up, and support designed to help you work toward sustainable weight-loss goals.
Starting at $299/month

Semaglutide belongs to a medication class called GLP-1 receptor agonists. It works on pathways involved in appetite and food intake and may support chronic weight management for eligible patients when combined with nutrition, activity, and sustainable routines.
Reniel Health provides private telehealth evaluation for Maryland adults considering semaglutide. Your provider determines whether this treatment fits your health profile and explains the specific medication, formulation, dosing approach, risks, and follow-up plan being considered.
Your provider reviews your health history, current medications, goals, and potential risks before recommending care. Booking a visit does not guarantee a prescription.
A semaglutide visit considers weight history, weight-related conditions, current prescriptions, previous approaches, family history, pregnancy plans, and other factors that can influence safety or treatment selection.
Semaglutide treatment uses a provider-directed dosing plan. Follow-up gives you a place to discuss tolerability, side effects, appetite changes, progress, and practical barriers before any adjustment is considered.
Medication does not replace healthy eating or physical activity. Your long-term plan should support habits that remain useful beyond a single dose or prescription cycle.
Choose your visit and complete a secure health intake from home.
Meet by telehealth to review your history, symptoms, goals, and options.
If treatment is appropriate, receive a personalized plan and follow-up guidance.
Clear expectations make it easier to choose your next step with confidence.
Semaglutide is a GLP-1 receptor agonist. It acts on pathways involved in appetite and food intake. Whether it is appropriate for you depends on medical evaluation.
No. Your provider reviews your personal and family history, current medications, potential contraindications, and treatment goals before recommending semaglutide or another pathway.
Dose decisions are made by your provider. Treatment commonly begins at a lower dose and may be adjusted over time based on clinical guidance and tolerability.
Medication products, formulations, pharmacy fulfillment, and prices may vary. Your treatment plan will identify the specific option being considered before you proceed.
Begin with a private telehealth visit from anywhere in Maryland.